We ask how viruses manipulate host organelles and innate immunity — and turn those answers into vaccines and antivirals for diseases that still have no good options.
We aim to define the molecular mechanisms of viral pathogenesis, with a particular focus on the mitochondrial, nuclear and lysosomal dynamics that viruses exploit to replicate, evade innate immunity and persist in the host.
Discovery should not stop at the bench. We translate mechanistic insight into vaccine candidates and antiviral strategies for emerging and re-emerging infectious diseases with unmet medical needs.
The lab is built on classical molecular virology — infectious clones, replicon systems, BSL-2/3 virology — combined with cell biology, imaging, CRISPR screening and animal models of infection. We work closely with chemists, structural biologists and clinicians, a habit carried over from years of national emerging-virus response programs.
Rigorous experiments, honest data and a collegial bench culture. We welcome students and researchers who are curious about how viruses work and willing to follow a question wherever it leads.